In Memory of Dr. Michael Rinck, Founder, MT Promedt Consulting GmbH
September 24, 2026
It is with great sadness and a heavy heart that we inform you that our former Managing Director and company founder, Dr. Michael Rinck, passed away on September 10, 2026, at the age of 73.
Dr. Michael Rinck founded our company in 1995 and, over many decades, shaped it with immense dedication, vision, and human warmth. It is thanks to his courage and his values that we have the foundation upon which our company still stands today. Even after stepping down from active management in 2022, he remained closely connected to us as a highly regarded figure and mentor.
We will honor Michael’s memory and continue to run the company in his spirit.
Our heartfelt sympathy goes out to his family and loved ones during this difficult time.
MT Promedt Consulting GmbH
Recent News
- In Memory of Dr. Michael Rinck, Founder, MT Promedt Consulting GmbH
- bioMérieux Launches SPINCHIP® hs-cTnl, a Major Innovation for the Measurement of High-Sensitivity Cardiac Troponin I and Faster Management of Cardiac Emergencies
- Priority Review Granted for PolarityBio’s SkinTE for Treatment of Diabetic Foot Ulcers
- National Institutes of Health Award Inherent Biosciences a Direct-to-Phase II SBIR Grant
- Co-Diagnostics to Participate in Global Health Roundtable on Ebola and Outbreak Innovation
- Epitel’s REMI Neuro Monitoring System Selected for the FDA’s READI-Home Innovation Challenge
